RecruitingNCT07299097

Epidemiology of Narcolepsy Type 1 and Type 2 in Spain

Sponsor

Takeda

Enrollment

100 participants

Start Date

Dec 2, 2025

Study Type

OBSERVATIONAL

Conditions

Narcolepsy Type 1 Narcolepsy Type 2

Summary

The main purpose of this study is to find out how many people in Spain have been diagnosed with narcolepsy type 1 and type 2, and how many new participants are diagnosed each year. Narcolepsy is a rare sleep disorder that causes excessive daytime sleepiness. The researchers will look at medical records from hospitals across Spain to count participants with these conditions and understand patterns in diagnosis over time.

Eligibility

Min Age: 0 Years

Inclusion Criteria8

\- Core Group:
Participants with NT1 or NT2 following International Classification of Sleep Disorders, 3rd Edition (ICSD-3) or ICSD-3 text revision (ICSD-3-TR) criteria who are alive at any point during 2023 or 2024.
Any age, ethnicity and nationality.
Treated / under follow-up in the study site and residing in the hospitals' reference areas. Consideration will be given if participants have changed their address or reached adulthood.
Confirmation to have a diagnosis of NT1 or NT2 by a specialist.
Participants greater than equal to (≥) 18 years or parents of narcolepsy participants under 18 years of age.
Any gender, ethnicity or nationality.
Residence in Spain.

Exclusion Criteria3

\. NT1 or NT2 participants who do not reside in the hospitals' reference areas.
\- Supplementary Group:
\. Participants without a confirmed NT1 or NT2 diagnosis by a specialist.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

As this is an observational study, no intervention will be administered.

Locations(10)

Hospital General de Castellón

Castellon, Castellon, Spain

Hospital de Navarra

Pamplona, Navarre, Spain

Hospital de la Ribera

Alzira, Valencia, Spain

Hospital Vall d'Hebrón

Barcelona, Spain

Hospital Clinic de Barcelona

Barcelona, Spain

Hospital Virgen de las Nieves

Granada, Spain

Hospital Clínico San Carlos

Madrid, Spain

Hospital La Paz

Madrid, Spain

Hospital Virgen Macarena

Seville, Spain

Hospital de Araba

Vitoria-Gasteiz, Álava, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07299097

Related Trials

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

NCT0709667414 locations

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

NCT0676768346 locations